Jonathan W. Dickerson

1.0k total citations
29 papers, 644 citations indexed

About

Jonathan W. Dickerson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Jonathan W. Dickerson has authored 29 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cellular and Molecular Neuroscience, 18 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in Jonathan W. Dickerson's work include Receptor Mechanisms and Signaling (17 papers), Neuroscience and Neuropharmacology Research (16 papers) and Nicotinic Acetylcholine Receptors Study (7 papers). Jonathan W. Dickerson is often cited by papers focused on Receptor Mechanisms and Signaling (17 papers), Neuroscience and Neuropharmacology Research (16 papers) and Nicotinic Acetylcholine Receptors Study (7 papers). Jonathan W. Dickerson collaborates with scholars based in United States, Denmark and France. Jonathan W. Dickerson's co-authors include P. Jeffrey Conn, Kim B. Seroogy, Craig W. Lindsley, Ann M. Hemmerle, Jerri M. Rook, Colleen M. Niswender, Zixiu Xiang, Carrie K. Jones, Darren W. Engers and Anna L. Blobaum and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and The Journal of Comparative Neurology.

In The Last Decade

Jonathan W. Dickerson

27 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan W. Dickerson United States	15	419	370	87	75	73	29	644
Ning-Sheng Cai United States	15	485 1.2×	415 1.1×	82 0.9×	43 0.6×	93 1.3×	21	759
Marc Brugarolas Spain	9	390 0.9×	425 1.1×	61 0.7×	56 0.7×	43 0.6×	9	686
Jens Nagel Germany	18	490 1.2×	328 0.9×	104 1.2×	32 0.4×	110 1.5×	33	805
Paul M. Lea United States	10	335 0.8×	307 0.8×	51 0.6×	55 0.7×	95 1.3×	11	597
Hector De Jesús‐Cortés United States	11	186 0.4×	214 0.6×	96 1.1×	86 1.1×	51 0.7×	11	519
Catrin Wernicke Germany	18	249 0.6×	246 0.7×	82 0.9×	25 0.3×	92 1.3×	27	616
Peter Jeffrey Conn United States	6	407 1.0×	268 0.7×	36 0.4×	76 1.0×	83 1.1×	7	510
Verònica Casadó-Anguera Spain	13	317 0.8×	347 0.9×	85 1.0×	27 0.4×	69 0.9×	22	592
Joeri Van Liefferinge Belgium	14	279 0.7×	228 0.6×	51 0.6×	58 0.8×	39 0.5×	19	597
Hong‐Jin Shu United States	16	548 1.3×	458 1.2×	33 0.4×	44 0.6×	97 1.3×	27	916

Countries citing papers authored by Jonathan W. Dickerson

Since Specialization

Citations

This map shows the geographic impact of Jonathan W. Dickerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan W. Dickerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan W. Dickerson more than expected).

Fields of papers citing papers by Jonathan W. Dickerson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan W. Dickerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan W. Dickerson. The network helps show where Jonathan W. Dickerson may publish in the future.

Co-authorship network of co-authors of Jonathan W. Dickerson

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan W. Dickerson. A scholar is included among the top collaborators of Jonathan W. Dickerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan W. Dickerson. Jonathan W. Dickerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Engers, Julie L., Changho Han, Alison R. Gregro, et al.. (2025). Application of Deuterium in an M₁ Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422. ACS Chemical Neuroscience. 16(8). 1582–1591.

Engers, Julie L., Aaron M. Bender, Jonathan W. Dickerson, et al.. (2024). Discovery of VU6007496: Challenges in the Development of an M₁ Positive Allosteric Modulator Backup Candidate. ACS Chemical Neuroscience. 15(18). 3421–3433. 3 indexed citations

Rook, Jerri M., Zixiu Xiang, Jonathan W. Dickerson, et al.. (2023). M1 Positive Allosteric Modulators Enhance Domains of Cognitive Function by Activation of ssT-expressing Interneurons in the Prefrontal Cortex. Journal of Pharmacology and Experimental Therapeutics. 385. 407–407. 1 indexed citations

Qi, Aidong, Alice L. Rodriguez, Peng Li, et al.. (2023). Development of a Selective and High Affinity Radioligand, [3H]VU6013720, for the M4 Muscarinic Receptor. Molecular Pharmacology. 104(5). 195–202. 2 indexed citations

Bender, Aaron M., Sheila Shay, Santhi Gladson, et al.. (2023). Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial Hypertension. JACC Basic to Translational Science. 8(10). 1379–1388. 6 indexed citations

Barbaro, Lisa, Alice L. Rodriguez, Jonathan W. Dickerson, et al.. (2021). Discovery of “Molecular Switches” within a Series of mGlu₅ Allosteric Ligands Driven by a “Magic Methyl” Effect Affording Both PAMs and NAMs with In Vivo Activity, Derived from an M₁ PAM Chemotype. SHILAP Revista de lepidopterología. 1(1). 21–30. 3 indexed citations

Dickerson, Jonathan W., Alice L. Rodriguez, Anna L. Blobaum, et al.. (2021). Discovery and optimization of a novel CNS penetrant series of mGlu4 PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian model. Bioorganic & Medicinal Chemistry Letters. 37. 127838–127838. 5 indexed citations

Bender, Aaron M., Alice L. Rodriguez, Jonathan W. Dickerson, et al.. (2021). Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M4 muscarinic acetylcholine receptor. Bioorganic & Medicinal Chemistry Letters. 56. 128479–128479. 3 indexed citations

Rook, Jerri M., Hyekyung P. Cho, Pedro M. García-Barrantes, et al.. (2018). A Novel M ₁ PAM VU0486846 Exerts Efficacy in Cognition Models without Displaying Agonist Activity or Cholinergic Toxicity. ACS Chemical Neuroscience. 9(9). 2274–2285. 45 indexed citations

10.

Moran, Sean P., Jonathan W. Dickerson, Hyekyung P. Cho, et al.. (2018). M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition. Neuropsychopharmacology. 43(8). 1763–1771. 58 indexed citations

11.

Lv, Xiaohui, Jonathan W. Dickerson, Jerri M. Rook, et al.. (2017). M 1 muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons. Neuropharmacology. 118. 209–222. 29 indexed citations

12.

Walker, Adam G., Douglas J. Sheffler, Andrew Lewis, et al.. (2017). Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation. Neuropsychopharmacology. 42(13). 2553–2566. 16 indexed citations

13.

Ghoshal, Ayan, Jerri M. Rook, Jonathan W. Dickerson, et al.. (2015). Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model. Neuropsychopharmacology. 41(2). 598–610. 81 indexed citations

14.

Hemmerle, Ann M., Jonathan W. Dickerson, James P. Herman, & Kim B. Seroogy. (2013). Stress exacerbates experimental Parkinson’s disease. Molecular Psychiatry. 19(6). 638–640. 47 indexed citations

15.

Suidan, Georgette L., Jonathan W. Dickerson, Holly L. Johnson, et al.. (2012). Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability. Journal of Neuroinflammation. 9(1). 218–218. 16 indexed citations

16.

Hemmerle, Ann M., Jonathan W. Dickerson, Nicole R. Herring, et al.. (2012). (±)3,4‐methylenedioxymethamphetamine (“ecstasy”) treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain. The Journal of Comparative Neurology. 520(11). 2459–2474. 28 indexed citations

17.

Jones, Carrie K., Michael Bubser, Analisa D. Thompson, et al.. (2011). The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease. Journal of Pharmacology and Experimental Therapeutics. 340(2). 404–421. 81 indexed citations

18.

Dickerson, Jonathan W.. (2010). Neuroprotective and neurorestorative effects of neuregulins in the injured and aged dopaminergic nigrostriatal system. OhioLink ETD Center (Ohio Library and Information Network). 2 indexed citations

19.

Suidan, Georgette L., Jonathan W. Dickerson, Yi Chen, et al.. (2009). CD8 T Cell-Initiated Vascular Endothelial Growth Factor Expression Promotes Central Nervous System Vascular Permeability under Neuroinflammatory Conditions. The Journal of Immunology. 184(2). 1031–1040. 55 indexed citations

20.

Dickerson, Jonathan W., Ann M. Hemmerle, Suzanne Numan, Kerstin H. Lundgren, & Kim B. Seroogy. (2009). Decreased expression of ErbB4 and tyrosine hydroxylase mRNA and protein in the ventral midbrain of aged rats. Neuroscience. 163(1). 482–489. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact